A modified multiparametric assay using HepaRG cells for predicting the degree of drug-induced liver injury risk

2016 ◽  
Vol 37 (3) ◽  
pp. 382-390 ◽  
Author(s):  
Takafumi Tomida ◽  
Hayao Okamura ◽  
Tsuyoshi Yokoi ◽  
Yoshihiro Konno
Keyword(s):  
Liver Injury ◽  
Injury Risk ◽  
Drug Induced ◽  
Drug Induced Liver Injury ◽  
Heparg Cells

New Perspectives on Drug-Induced Liver Injury Risk Assessment of Acyl Glucuronides

2020 ◽  
Vol 33 (7) ◽  
pp. 1551-1560 ◽  
Author(s):  
Markus Walles ◽  
Alan P. Brown ◽  
Alfred Zimmerlin ◽  
Peter End
Keyword(s):  
Risk Assessment ◽  
Liver Injury ◽  
Injury Risk ◽  
Drug Induced ◽  
Drug Induced Liver Injury ◽  
Acyl Glucuronides

In vitro assessment of farnesoid X receptor antagonism to predict drug-induced liver injury risk

2020 ◽  
Vol 94 (9) ◽  
pp. 3185-3200
Author(s):  
Leah M. Norona ◽  
Aaron Fullerton ◽  
Chris Lawson ◽  
Leslie Leung ◽  
Jochen Brumm ◽  
...  
Keyword(s):  
Liver Injury ◽  
Injury Risk ◽  
Farnesoid X Receptor ◽  
Drug Induced ◽  
Receptor Antagonism ◽  
Drug Induced Liver Injury ◽  
In Vitro Assessment

Multiparametric assay using HepaRG cells for predicting drug-induced liver injury

2015 ◽  
Vol 236 (1) ◽  
pp. 16-24 ◽  
Author(s):  
Takafumi Tomida ◽  
Hayao Okamura ◽  
Masahiro Satsukawa ◽  
Tsuyoshi Yokoi ◽  
Yoshihiro Konno
Keyword(s):  
Liver Injury ◽  
Drug Induced ◽  
Drug Induced Liver Injury ◽  
Heparg Cells

Assessment of Serious Acute and Chronic Idiosyncratic Drug-Induced Liver Injury in Clinical Practice

2019 ◽  
Vol 39 (03) ◽  
pp. 381-394 ◽  
Author(s):  
Fernando Bessone ◽  
Mercedes Robles-Diaz ◽  
Nelia Hernandez ◽  
Inmaculada Medina-Caliz ◽  
M. Isabel Lucena ◽  
...  
Keyword(s):  
Liver Injury ◽  
Injury Risk ◽  
Acute Liver Injury ◽  
Developed Countries ◽  
Drug Induced ◽  
Drug Induced Liver Injury ◽  
Injury Risk Factors ◽  
Variable Phenotype ◽  
Hy’S Law ◽  
Scoring Algorithms

AbstractDrug-induced liver injury (DILI) is the leading cause of acute liver failure (ALF) in developed countries. The extremely variable phenotype of DILI, both in presentation and in severity, is one of the distinctive characteristics of the disease and one of the major challenges that hepatologists face when assessing hepatotoxicity cases. A new Hy's law that more accurately predicts the risk of ALF related to DILI has been proposed and validated. Other prognostic scoring algorithms for the early identification of DILI patients who may go on to develop ALF have been developed as it is of most clinical relevance to stratify patients for closer monitoring. Recent data indicate that acute DILI often presents a more prolonged resolution or evolves into chronicity at a higher frequency than other forms of acute liver injury. Risk factors for chronicity, specific phenotypes, and histological features are discussed in this study. Biomarkers to predict DILI outcome are in need.

scholarly journals Design and synthesis of acetaminophen probe APAP-P1 for identification of the toxicity targets thioredoxin reductase-1 in HepaRG cells

RSC Advances ◽  
2019 ◽  
Vol 9 (27) ◽  
pp. 15224-15228
Author(s):  
Shan Wang ◽  
Yu Tian ◽  
Shan Lu ◽  
Ruiying Wang ◽  
Hai Shang ◽  
...  
Keyword(s):  
Liver Injury ◽  
Drug Administration ◽  
Drug Withdrawal ◽  
Food And Drug Administration ◽  
Thioredoxin Reductase ◽  
Drug Induced ◽  
Drug Induced Liver Injury ◽  
Design And Synthesis ◽  
Thioredoxin Reductase 1 ◽  
Heparg Cells

Drug-induced liver injury is one of the main causes of drug non-approval and drug withdrawal by the Food and Drug Administration (FDA).

Sign in / Sign up

Export Citation Format

Share Document